Loading clinical trials...
Loading clinical trials...
To evaluate glaucoma patients' response to treatment with Xiidra, an FDA-approved drug for ocular surface discomfort, which will be prescribed as standard of care treatment.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
University of California, Los Angeles
Collaborators
NCT07539675 · Primary Angle-Closure Glaucoma
NCT06289491 · Glaucoma, Glaucoma, Open-Angle
NCT07496957 · GLAUCOMA 1, OPEN ANGLE, D (Disorder)
NCT07455786 · Glaucoma
NCT07298356 · Glaucoma, Glaucoma, Suspect
Doheny Eye Center UCLA
Fountain Valley, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions